1. 2009
  2. To what degree do patients with advanced lung cancer want to be informed and involved in medical decision-making? A multicentre study in 13 hospitals in Belgium

    Pardon, K., Van Meerbeeck, J., Schallier, D., Germonpre, P., Galdermans, D., Van Kerckhoven, W., Bernheim, J., Deschepper, R., Mortier, F., Vander Stichele, R. & Deliens, L., 2009, In : Journal of Thoracic Oncology. 4, September, p. 541-542 2 p.

    Research output: Contribution to journalMeeting abstract (Journal)

  3. Toxicity report of a phase I/II dose escalation study in inoperable locally advanced non-small cell lung cancer with helical tomotherapy and concurrent chemotherapy

    Bral, S., Versmessen, H., Duchateau, M., Schallier, D., Everaert, H. & Storme, G., 2009, In : European Journal of Cancer. Supplement. 7, September, p. 535-535 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)

  4. 2008
  5. Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide

    Neyns, B., Cordera, S., Joosens, E. & Pouratian, N., 20 Sep 2008, In : J Clin Oncol. 26, J Clin Oncol. 2009 Jun, p. 4518-4519 2 p.

    Research output: Contribution to journalArticle

  6. CETUXIMAB WITH HEPATIC ARTERIAL INFUSION OF CHEMOTHERAPY FOR THE TREATMENT OF COLORECTAL CANCER LIVER METASTASES

    Neyns, B., Aerts, M., Van Nieuwenhove, Y., Fontaine, C., Decoster, L., Schallier, D., Van Der Auwera, J., De Munck, F., Vandenbroucke, F., Everaert, H., Meert, V., De Mey, J., De Ridder, M., Delvaux, G. & De Greve, J., 1 Jan 2008, Anticancer Research. Vol. 28. p. 4-4 1 p. (Anticancer Research).

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)

  7. A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma

    Neyns, B., Chaskis, C., Joosens, E., Menten, J., D'hondt, L., Branle, F., Sadones, J. & Michotte, A., 2008, In : Cancer Invest.. 26, April-May, p. 269-277 9 p.

    Research output: Contribution to journalArticle

  8. A MULTICENTER STRATIFIED PHASE II STUDY OF CETUXIMAB FOR THE TREATMENT OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

    Neyns, B., Sadones, J., Joossens, E. J. R., Bouttens, F., Verbeke, L., Baurain, J., D'hondt, L., Strauven, T., Chaskis, C. & Michotte, A., 2008, In : Neuro-Oncology. 10, December, p. 1067-1067 1 p.

    Research output: Contribution to journalConference paper

  9. An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

    Van Cutsem, E., Siena, S., Humblet, Y., Canon, J-L., Maurel, J., Bajetta, E., Neyns, B., Kotasek, D., Santoro, A., Sheithauer, W., Spadafora, S., Amado, R. G. & Hogan, N., 2008, In : Ann Oncol. 19, January, p. 92-98 7 p.

    Research output: Contribution to journalArticle

  10. Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis

    Neyns, B., Meert, V. & Vandenbroucke, F., 2008, In : Curr Oncol. 15, 4, p. 196-197 2 p.

    Research output: Contribution to journalArticle

ID: 25692